Friendship group affiliated to HVN

Hello Wendy

As requested, please see response below.

REQUEST:   

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: -

1. Please supply patient’s information ECT leaflet – Enclosed

2. Please supply patient ECT consent form – Enclosed

3. Please supply any ECT reports/investigations - We would not supply restraint investigation reports as they could be patient identifiable.

4. How many ECT in 2024? - 113

5. What proportion of patients were men/women? - 58% female and 48% Male

6. How old were they? All 18+

7. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME") 4

8. How many people covered by the equality act - specific protected characteristics - excluding age + gender - received ECT? - Not collated information

9. How many people were offered talking therapy prior to ECT? - Not collated information

10. How many were receiving ECT for the first time? Information is not collated

11. How many patients consented to ECT? 33

12. How many ECT complaints were investigated outside the NHS? No complaints received in 2024

13. How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)? - Not collated information

14. How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)? - Not collated information

15. How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)? - Not collated information/not recorded

16. How many patients have suffered complications during and after ECT and what were those complications? 1 patient suffered total heart block whilst recovering from treatment

17. Have there been any formal complaints from patients/relatives about ECT? - It is not possible to quantify complaints regarding ECT as we do not record complaints against this specific procedure

18. If so, what was their concerns? – Not Available

19. How many patients report memory loss/loss of cognitive function? 17

20. What tests are used to assess memory loss/loss of cognitive function? - 6 CIT, patient orientation assessment devised by the Trust.

21. Have MRI or CT scans been used before and after ECT? - Not as routine, only when clinically indicated to inform suitability for treatment

22. If so, what was the conclusion? - Unable to answer as only used to inform suitability for treatment

23. How does the Trust plan to prevent ECT in the future? - The Trust is committed to using evidence-based treatment as prescribed by NICE. Transcranial Magnetic Stimulation is NICE indicated treatment that is being considered as an alternative to ECT where indicated.

Please provide RESTRAINTS information under the FOI act to the following questions:

1. Please supply any Restraints/investigations - We would not supply restraint investigation reports as they could be patient identifiable.

2. How many RESTRAINTS in 2024? – 3614

3. What proportion of patients were men/women? - 55% men, 44.9% women, 0.1% other (this is calculated based on number of incidents of restraint)

4. How old were they? – see table below

(this is calculated based on number of incidents of restraint)

5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? - 6.56% (this is calculated based on number of incidents of restraint) NB: ethnicity not stated in 2.7% incidents of seclusion

6. How many people covered by the equality act - specific protected characteristics - excluding age + gender - were restrained - Data not held in Incident Reports

7. How many RESTRAINTS were investigated outside the NHS? – We do not have this data

8. How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? - We do not hold that data so cannot provide

9. How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? - We do not hold that data so cannot provide

10. How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)? - We do not hold that data so cannot provide

11. How many patients have suffered complications during and after RESTRAINTS and what were those complications? - We do not hold that data so cannot provide

12. Have there been any formal complaints from patients/relatives about RESTRAINTS? - 2

If so, what was their concerns? – Included an allegation of injury during restraint and having clinical tests completed under restraint.

13. Are counts of forced injections available? if so, how many people were forcible injected? - Data is reported internally

14. How does the Trust plan to reduce restraints in the future? - The trust has a reducing restrictive practices agenda and work plan which is supported by a team of specialist nurses

15. How many of these restraints were face down restraints? - 2

Please provide SECLUSION information under the FOI act to the following questions: -

1. Please supply any SECLUSION reports/investigations - We would not supply individual investigation reports as they could be patient identifiable.

2. How many SECLUSIONS in 2024? - 556 (this is calculated based on number of incidents of seclusion)

3. What proportion of patients were men/women? - 64.4% male, 35.2% female (this is calculated based on number of incidents of seclusion)

4. How old were they? – see table below

           *  (this is calculated based on number of incidents of seclusion)*

5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? - 13.67% (this is calculated based on number of incidents of seclusion). NB: ethnicity not stated in 3.6% incidents of seclusion

6. How many people covered by the equality act - specific protected characteristics - excluding age + gender - were secluded? - Do not have this data

7. How many SECLUSIONS were investigated outside the NHS? - Do not have this data

8. How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? - We do not hold that data so cannot provide

9. How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? - We do not hold that data so cannot provide

10. How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)? - We do not hold that data so cannot provide

11. How many patients have suffered complications during and after SECLUSION and what were those complications? - We do not hold that data so cannot provide

12. Have there been any formal complaints from patients/relatives about SECLUSION? - We do not record complaints against this specific intervention

13. If so, what was their concerns? – Not available

14. How does the Trust plan to reduce SECLUSIONS in the future? - The trust has a reducing restrictive practices agenda and work plan which is supported by a team of specialist nurses

Please provide MEDICATION ERRORS information under the FOI act to the following questions:

1. Please supply any MEDICATION ERRORS reports/investigations - We would not supply individual investigation reports as they could be patient identifiable

2. How many MEDICATION ERRORS in 2024? - 2066 medication errors were reported on our incident reporting system in 2024

3. What proportion of patients were men/women? - 30.59% were female, 32.04% were male, 37.37% not stated

4. How old were they? See table below

5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?  - See table below

6. How many people covered by the equality act - specific protected characteristics - excluding age + gender - endured medication errors? - Data not held in Incident Reports

7. How many MEDICATION ERRORS were investigated outside the NHS? - We do not hold that data

8. How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? - We do not hold that data so cannot provide

9. How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? - We do not hold that data so cannot provide

10. How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)? - We do not hold that data so cannot provide

11. How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications? - We do not hold that data so cannot provide

12. Have there been any formal complaints from patients/relatives about MEDICATION ERRORS? - In the financial year the trust has received eight complaints indicating potential medication errors.

13. If so, what was their concerns? - The descriptors of these concerns were:

• Wrong dosage of medication given

• Near miss – medication administration

• Problems with medication

14. How does the Trust plan to prevent MEDICATION ERRORS in the future? - The Trust prepares quarterly medication incident reports containing an analysis of themes.  These reports are tabled at the Medication Safety Group, Drugs and Therapeutics Group, Network Governance Groups and are also sent to Commissioners.  Medicines management nurses review all incident reports involving medication and provide immediate support e.g. additional training, competency review where this has been identified as a need.  The Medication Safety Group agree any additional action needed in response to key themes from the quarterly medication incident reports and incorporate these into the Medication Safety annual work plan.

Many Thanks!

Rosemary Kolo

Freedom of Information (FOI) Lead

Lancashire & South Cumbria NHS Foundation Trust